Form 8-K - Current report:
SEC Accession No. 0001140361-25-005988
Filing Date
2025-02-26
Accepted
2025-02-26 07:22:06
Documents
17
Period of Report
2025-02-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20044296_8k.htm   iXBRL 8-K 39552
2 EXHIBIT 99.1 ef20044296_ex99-1.htm EX-99.1 212430
6 image00002.jpg GRAPHIC 3886
7 image00004.jpg GRAPHIC 3276
8 image00005.jpg GRAPHIC 3479
  Complete submission text file 0001140361-25-005988.txt   433927

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA imcr-20250225.xsd EX-101.SCH 3991
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE imcr-20250225_lab.xml EX-101.LAB 21966
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imcr-20250225_pre.xml EX-101.PRE 16050
19 EXTRACTED XBRL INSTANCE DOCUMENT ef20044296_8k_htm.xml XML 4287
Mailing Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY
Business Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY 01235 5430281
Immunocore Holdings plc (Filer) CIK: 0001671927 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39992 | Film No.: 25666149
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)